PS Ratio
6.37
-0.10-1.55%
Sat, 08 Feb 2025 00:31:11 GMT
Summary
- As of February 8, 2025, XLO price to sales ratio is 6.37, with a fall of -0.10 (-1.55%) during the most recent trading day.
- XLO PS ratio is now -67.15% below its all-time high of 19.39.
Performance
XLO PS Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
PS Ratio Formula
P/S = Market capitalization
TTM Revenue
Market capitalization
TTM Revenue
TTM Revenue
XLO PS Ratio Trends
PeriodPeriod | PS ratioPS ratio | PricePrice | Market capMarket cap | TTM revenueTTM revenue |
---|---|---|---|---|
todaytoday | -1.6% | -1.5% | -1.5% | +96.0% |
1 m1 month | -33.7% | -33.7% | -33.7% | - |
3 m3 months | -46.4% | -46.4% | -46.4% | 0.0% |
6 m6 months | -60.4% | -22.3% | -22.3% | - |
ytdytd | -29.5% | -29.5% | -29.5% | - |
1 y1 year | - | +6.3% | +69.3% | - |
5 y5 years | - | - | - | - |
XLO PS Ratio Highs & Lows
PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
---|---|---|---|---|---|
1 m | 1-month | -43.7% | 6.37 | at low | |
3 m | 3-month | 13.04 | -51.1% | 6.37 | at low |
6 m | 6-month | 17.38 | -63.4% | 6.37 | at low |
1 y | 1-year | 19.39 | -67.2% | 6.37 | at low |
3 y | 3-year | 19.39 | -67.2% | 6.37 | at low |
5 y | 5-year | 19.39 | -67.2% | 6.37 | at low |
alltime | all time | 19.39 | -67.2% | 6.37 | at low |
Xilio Therapeutics PS Ratio History
Date | Value |
---|---|
2025 | 6.37(-29.5%) |
Date | Value |
---|---|
2024 | 9.04 |
FAQ
- What is Xilio Therapeutics price to sales ratio?
- What is the all time high PS ratio for Xilio Therapeutics?
- What is XLO price to sales ratio year-to-date change?
What is Xilio Therapeutics price to sales ratio?
The current PS ratio of XLO is 6.37
What is the all time high PS ratio for Xilio Therapeutics?
Xilio Therapeutics all-time high price to sales ratio is 19.39
What is XLO price to sales ratio year-to-date change?
Xilio Therapeutics price to sales ratio has changed by -2.67 (-29.54%) since the beginning of the year